Literature DB >> 8182579

Quick freezing of unfertilized mouse oocytes using ethylene glycol with sucrose or trehalose.

A A Rayos1, Y Takahashi, M Hishinuma, H Kanagawa.   

Abstract

Unfertilized mouse oocytes were frozen by directly plunging them into liquid nitrogen vapour after equilibration in a freezing medium containing 3 mol ethylene glycol l-1 with 0.25 mol sucrose or trehalose l-1 for 5-40 min. After thawing and dilution of the cryoprotectant, oocytes of normal morphology were inseminated in vitro and the effect of equilibration period on the rates of fertilization and development in vitro was examined. Regardless of the equilibration in the freezing medium, no significant difference was observed on the fertilization rate of frozen-thawed oocytes. However, higher fertilization and higher normal fertilization rates were obtained with equilibration in 3 mol ethylene glycol l-1 with either 0.25 mol sucrose l-1 or trehalose for 20 and 40 min than with 5 and 10 min equilibration. Development rates to two-cell embryos and expanded blastocysts of in vitro fertilized frozen-thawed oocytes that were equilibrated in the freezing medium for 20 and 40 min were significantly higher (P < 0.05 or P < 0.01) than with 5 min equilibration. Development in vivo was assessed by transferring blastocysts derived from unfertilized oocytes frozen by the optimum treatment (20 min equilibration in the freezing medium before freezing) into the uterine horns of day 3 pseudopregnant female recipients. The development rate of frozen-thawed oocytes to the blastocyst stage after insemination in vitro was significantly lower than that of the non-frozen control (P < 0.001). However, transfer of the blastocysts derived from frozen-thawed oocytes to the uterine horns of the recipients in fetal development and implantation rates similar to those of the control.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182579     DOI: 10.1530/jrf.0.1000123

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  7 in total

1.  In vitro culture of mouse GV oocytes and preantral follicles isolated from ovarian tissues cryopreserved by vitrification.

Authors:  Miwa Segino; Mario Ikeda; Sigeru Aoki; Yuko Tokieda; Fumiki Hirahara; Kahei Sato
Journal:  Hum Cell       Date:  2003-09       Impact factor: 4.174

2.  Emerging technologies in medical applications of minimum volume vitrification.

Authors:  Xiaohui Zhang; Paolo N Catalano; Umut Atakan Gurkan; Imran Khimji; Utkan Demirci
Journal:  Nanomedicine (Lond)       Date:  2011-08       Impact factor: 5.307

3.  Developmental potential and ultrastructural injuries of metaphase II (MII) mouse oocytes after slow freezing or vitrification.

Authors:  Mojtaba Rezazadeh Valojerdi; Mojdeh Salehnia
Journal:  J Assist Reprod Genet       Date:  2005-03       Impact factor: 3.412

4.  Nanoliter droplet vitrification for oocyte cryopreservation.

Authors:  Xiaohui Zhang; Imran Khimji; Lei Shao; Hooman Safaee; Khanjan Desai; Hasan Onur Keles; Umut Atakan Gurkan; Emre Kayaalp; Aida Nureddin; Raymond M Anchan; Richard L Maas; Utkan Demirci
Journal:  Nanomedicine (Lond)       Date:  2011-12-21       Impact factor: 5.307

Review 5.  Human oocyte and ovarian tissue cryopreservation and its application.

Authors:  Tao Tao; Alfonso Del Valle
Journal:  J Assist Reprod Genet       Date:  2008-08-01       Impact factor: 3.412

6.  Simplified EM grid vitrification is a convenient and efficient method for mouse mature oocyte cryopreservation.

Authors:  Seok Hyun Kim; Seung-Yup Ku; Ki Cheong Sung; Moon Joo Kang; Sung Ah Kim; Hee Sun Kim; Sun Kyung Oh; Byung Chul Jee; Chang Suk Suh; Young Min Choi; Jung Gu Kim; Shin Yong Moon
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

7.  Human oocyte vitrification: the permeability of metaphase II oocytes to water and ethylene glycol and the appliance toward vitrification.

Authors:  Steven F Mullen; Mei Li; Yuan Li; Zi-Jiang Chen; John K Critser
Journal:  Fertil Steril       Date:  2007-08-06       Impact factor: 7.329

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.